Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 3
Abstract
Introduction: There is scarcity of data in literature regarding the treatment response with Sofosbuvir (SOF) based therapy in Indian patients with chronic Hepatitis-C Virus (HCV) infection. Aim: This study was designed to observe initial treatment response to SOF based therapy in a “real-life” cohort of Indian patients with HCV infection. Materials and Methods: This is a prospective, observational and single center study. A total of 107 patients who were diagnosed with chronic HCV infection and received SOF based treatment between March 2015 and December 2015 were included. The patients were treated with either triple drug regimen [SOF, Ribavirin (RBV) and Pegylated Interferon-α (Peg IFN-α)] or dual drug regimen (SOF and RBV) for either 12 or 24 weeks. The virological responses were obtained at baseline and thereafter weekly (up to four weeks) till viral load became undetected during treatment. Results: A total of 107 patients who received SOF based therapy for chronic HCV infection were included in the study. Mean age of the patients was 48.7±10.7 years. Among included patients, 24 (22.4%) patients were treatment-experienced. Majority of the patients (n=69; 64.5%) were infected with HCV genotype-3. Except one patient, all the included patients achieved virological response up to week-4 of the treatment. There was statistically insignificant association between virological response (up to four week of the treatment) and severity of the disease (cirrhosis and non-cirrhosis) or treatment status (treatment-naïve and treatment-experienced), or HCV genotype (genotype-1 and 3). Conclusion: The results of this observational study demonstrated rapid initial virological response of SOF based therapy in “real-life” cohort of Indian patients with chronic HCV infection. However, long-term follow-up data are needed to ensure the sustained antiviral efficacy of SOF based therapy.
Authors and Affiliations
Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania
Keywords
Related Articles
- EP ID EP334376
- DOI 10.7860/JCDR/2017/23184.9335
- Views 107
- Downloads 0
Therapeutic Applications: Natural Killer Cells
ABSTRACT Natural Killer (NK) cells are potent cytotoxic effector cells for cancer therapy and also for keeping severe viral infections in check. Since, they represent only 10% of the lymphocytes and are often dysfunctio...
In vitro Evaluation of Resin Infiltrant Case Series Penetration into White Spot Lesions of Deciduous Molars
Introduction: Caries Infiltration is a recent microinvasive restorative technique that permits treatment of non-cavitated demineralized lesions, known as White Spot Lesions (WSL). Aim: To evaluate the extent of penetrati...
Pure Primary Squamous Cell Carcinoma of Ovary – A Rare Case Report
Primary Squamous Cell Carcinoma (SCC) is a rare tumour which arises in a mature cystic teratoma, endometrioma or Brenner tumour. The pure variety arises from metaplasia of surface epithelium of ovary and it is the rarest...
A Case of Undiagnosed Diabetes Mellitus with Alcohol Dependence Presenting as Epilepsia Partialis Continua
Non-Ketotic Hyperglycaemia (NKH) or hyperosmolar hyperglycaemic state is a rare cause of Epilepsia Partialis Continua (EPC) or any other types of seizures. However, it poses a diagnostic challenge when a previously undia...
Estimation of Salivary Tumour Necrosis Factor-α Levels in Post-menopausal Women with Chronic Periodontitis
ABSTRACT Introduction: Periodontitis and increased levels of Tumor Necrosis Factor-alpha (TNF-α) are considered as key factors contributing to the bone loss observed in oestrogen deficient post-menopausal women. Aim: The...